{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:10:16Z","timestamp":1791277816645,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,10,23]],"date-time":"2011-10-23T00:00:00Z","timestamp":1319328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1038\/nbt.1995","type":"journal-article","created":{"date-parts":[[2011,10,23]],"date-time":"2011-10-23T13:19:49Z","timestamp":1319375989000},"page":"1028-1033","source":"Crossref","is-referenced-by-count":64,"title":["A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia"],"prefix":"10.1038","volume":"29","author":[{"given":"Lacramioara","family":"Ivanciu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Toso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paris","family":"Margaritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pavani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haein","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Schlachterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Clerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra D","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind","family":"Rose-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V","family":"Erbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valder R","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney M","family":"Camire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,23]]},"reference":[{"key":"BFnbt1995_CR1","doi-asserted-by":"publisher","first-page":"18627","DOI":"10.1074\/jbc.M802205200","volume":"283","author":"R Toso","year":"2008","unstructured":"Toso, R., Zhu, H. & Camire, R.M. The conformational switch from the factor X zymogen to protease state mediates exosite expression and prothrombinase assembly. J. Biol. Chem. 283, 18627\u201318635 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnbt1995_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1182\/blood-2010-08-300756","volume":"117","author":"MW Bunce","year":"2011","unstructured":"Bunce, M.W., Toso, R. & Camire, R.M. Zymogen-like factor Xa variants restore thrombin generation and effectively bypass the intrinsic pathway in vitro. Blood 117, 290\u2013298 (2011).","journal-title":"Blood"},{"key":"BFnbt1995_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jbiotec.2006.03.042","volume":"124","author":"U Hedner","year":"2006","unstructured":"Hedner, U. Mechanism of action, development and clinical experience of recombinant FVIIa. J. Biotechnol. 124, 747\u2013757 (2006).","journal-title":"J. Biotechnol."},{"key":"BFnbt1995_CR4","unstructured":"Roberts, H.R. & Ma,, A.D. Overview of inherited hemorrhagic disorders. in Hemostasis and Thrombosis: Basic Principles and Clinical Practice. (eds. Colman, R.W., Marder, V.J., Clowes, A.W., Gerorge, J.N. & Goldhaber, S.Z.) 877\u2013885 (Lippincott Williams & Wilkins, Philadelphia, 2006)."},{"key":"BFnbt1995_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V76.1.1.1","volume":"76","author":"KG Mann","year":"1990","unstructured":"Mann, K.G., Nesheim, M.E., Church, W.R., Haley, P.E. & Krishnaswamy, S. Surface dependent reactions of the vitamin K-dependent enzyme complexes. Blood 76, 1\u201316 (1990).","journal-title":"Blood"},{"issue":"suppl. 3","key":"BFnbt1995_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2516.2008.01708.x","volume":"14","author":"PM Mannucci","year":"2008","unstructured":"Mannucci, P.M. Back to the future: a recent history of haemophilia treatment. Haemophilia 14 (suppl. 3), 10\u201318 (2008).","journal-title":"Haemophilia"},{"key":"BFnbt1995_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1365-2141.2007.06657.x","volume":"138","author":"D DiMichele","year":"2007","unstructured":"DiMichele, D. Inhibitor development in haemophilia B: an orphan disease in need of attention. Br. J. Haematol. 138, 305\u2013315 (2007).","journal-title":"Br. J. Haematol."},{"key":"BFnbt1995_CR8","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1046\/j.1538-7836.2004.00710.x","volume":"2","author":"SC Darby","year":"2004","unstructured":"Darby, S.C. et al. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977\u20131999. J. Thromb. Haemost. 2, 1047\u20131054 (2004).","journal-title":"J. Thromb. Haemost."},{"key":"BFnbt1995_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2516.2004.00934.x","volume":"10","author":"PL Turecek","year":"2004","unstructured":"Turecek, P.L., Varadi, K., Gritsch, H. & Schwarz, H.P. FEIBA: mode of action. Haemophilia 10, 3\u20139 (2004).","journal-title":"Haemophilia"},{"key":"BFnbt1995_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2516.2008.01931.x","volume":"15","author":"E Berntorp","year":"2009","unstructured":"Berntorp, E. Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors. Haemophilia 15, 3\u201310 (2009).","journal-title":"Haemophilia"},{"issue":"suppl. 3","key":"BFnbt1995_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2516.2010.02257.x","volume":"16","author":"MA Escobar","year":"2010","unstructured":"Escobar, M.A. Health economics in haemophilia: a review from the clinician's perspective. Haemophilia 16 (suppl. 3), 29\u201334 (2010).","journal-title":"Haemophilia"},{"key":"BFnbt1995_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","volume":"99","author":"DM Monroe","year":"1997","unstructured":"Monroe, D.M., Hoffman, M., Oliver, J.A. & Roberts, H.R. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br. J. Haematol. 99, 542\u2013547 (1997).","journal-title":"Br. J. Haematol."},{"key":"BFnbt1995_CR13","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1046\/j.1538-7836.2003.00181.x","volume":"1","author":"S Butenas","year":"2003","unstructured":"Butenas, S., Brummel, K.E., Bouchard, B.A. & Mann, K.G. How factor VIIa works in hemophilia. J. Thromb. Haemost. 1, 1158\u20131160 (2003).","journal-title":"J. Thromb. Haemost."},{"key":"BFnbt1995_CR14","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1016\/S0021-9258(17)39811-3","volume":"259","author":"SN Gitel","year":"1984","unstructured":"Gitel, S.N., Medina, V.M. & Wessler, S. Inhibition of human activated Factor X by antithrombin III and alpha 1-proteinase inhibitor in human plasma. J. Biol. Chem. 259, 6890\u20136895 (1984).","journal-title":"J. Biol. Chem."},{"key":"BFnbt1995_CR15","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1172\/JCI111648","volume":"74","author":"AR Giles","year":"1984","unstructured":"Giles, A.R., Nesheim, M.E. & Mann, K.G. Studies of Factors V and VIII:C in an animal model of disseminated intravascular coagulation. J. Clin. Invest. 74, 2219\u20132225 (1984).","journal-title":"J. Clin. Invest."},{"key":"BFnbt1995_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1365-2141.1988.tb02405.x","volume":"69","author":"AR Giles","year":"1988","unstructured":"Giles, A.R., Mann, K.G. & Nesheim, M.E. A combination of factor Xa and phosphatidylcholine-phosphatidylserine vesicles bypasses factor VIII in vivo. Br. J. Haematol. 69, 491\u2013497 (1988).","journal-title":"Br. J. Haematol."},{"key":"BFnbt1995_CR17","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/pro.5560070401","volume":"7","author":"AR Khan","year":"1998","unstructured":"Khan, A.R. & James, M.N.G. Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes. Protein Sci. 7, 815\u2013836 (1998).","journal-title":"Protein Sci."},{"key":"BFnbt1995_CR18","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1002\/j.1460-2075.1989.tb08511.x","volume":"8","author":"W Bode","year":"1989","unstructured":"Bode, W. et al. The refined 1.9 \u00c5 crystal structure of human \u03b1-thrombin: Interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Trp insertion segment. EMBO J. 8, 3467\u20133475 (1989).","journal-title":"EMBO J."},{"key":"BFnbt1995_CR19","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1111\/j.1538-7836.2007.02719.x","volume":"5","author":"SN Tchaikovski","year":"2007","unstructured":"Tchaikovski, S.N., van Vlijmen, B.J., Rosing, J. & Tans, G. Development of a calibrated automated thrombography based thrombin generation test in mouse plasma. J. Thromb. Haemost. 5, 2079\u20132086 (2007).","journal-title":"J. Thromb. Haemost."},{"key":"BFnbt1995_CR20","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1111\/j.1538-7836.2005.01639.x","volume":"3","author":"A Schlachterman","year":"2005","unstructured":"Schlachterman, A. et al. Factor V Leiden improves in vivo hemostasis in murine hemophilia models. J. Thromb. Haemost. 3, 2730\u20132737 (2005).","journal-title":"J. Thromb. Haemost."},{"key":"BFnbt1995_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000071637","volume":"33","author":"PL Turecek","year":"2003","unstructured":"Turecek, P.L. et al. Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay. Pathophysiol. Haemost. Thromb. 33, 16\u201322 (2003).","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"BFnbt1995_CR22","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1172\/JCI32878","volume":"118","author":"MN Aljamali","year":"2008","unstructured":"Aljamali, M.N. et al. Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality. J. Clin. Invest. 118, 1825\u20131834 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnbt1995_CR23","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1182\/blood-2010-09-309732","volume":"117","author":"P Margaritis","year":"2011","unstructured":"Margaritis, P. et al. Catalytic domain modification and viral gene delivery of activated factor VII confers hemostasis at reduced expression levels and vector doses in vivo. Blood 117, 3974\u20133982 (2011).","journal-title":"Blood"},{"key":"BFnbt1995_CR24","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1053\/j.seminhematol.2008.03.018","volume":"45","author":"C Weeterings","year":"2008","unstructured":"Weeterings, C., Lisman, T. & de Groot, P.G. Tissue factor-independent effects of recombinant factor VIIa on hemostasis. Semin. Hematol. 45, S12\u2013S15 (2008).","journal-title":"Semin. Hematol."},{"key":"BFnbt1995_CR25","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1161\/01.ATV.0000031340.68494.34","volume":"22","author":"DM Monroe","year":"2002","unstructured":"Monroe, D.M., Hoffman, M. & Roberts, H.R. Platelets and thrombin generation. Arterioscler. Thromb. Vasc. Biol. 22, 1381\u20131389 (2002).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnbt1995_CR26","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1182\/blood-2003-05-1369","volume":"102","author":"M Tranholm","year":"2003","unstructured":"Tranholm, M. et al. Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A. Blood 102, 3615\u20133620 (2003).","journal-title":"Blood"},{"key":"BFnbt1995_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.thromres.2004.11.003","volume":"116","author":"LC Petersen","year":"2005","unstructured":"Petersen, L.C. et al. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study. Thromb. Res. 116, 75\u201385 (2005).","journal-title":"Thromb. Res."},{"key":"BFnbt1995_CR28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.V60.1.59.59","volume":"60","author":"PB Tracy","year":"1982","unstructured":"Tracy, P.B., Eide, L.L., Bowie, E.J.W. & Mann, K.G. Radioimmunoassay of factor V in human plasma and platelets. Blood 60, 59\u201363 (1982).","journal-title":"Blood"},{"key":"BFnbt1995_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1538-7836.2008.03253.x","volume":"7","author":"J Moss","year":"2009","unstructured":"Moss, J., Scharling, B., Ezban, M. & Moller, S.T. Evaluation of the safety and pharmacokinetics of a fast-acting recombinant FVIIa analogue, NN1731, in healthy male subjects. J. Thromb. Haemost. 7, 299\u2013305 (2009).","journal-title":"J. Thromb. Haemost."},{"key":"BFnbt1995_CR30","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1172\/JCI2006","volume":"101","author":"H Weiler-Guettler","year":"1998","unstructured":"Weiler-Guettler, H. et al. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J. Clin. Invest. 101, 1983\u20131991 (1998).","journal-title":"J. Clin. Invest."},{"key":"BFnbt1995_CR31","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1182\/blood-2008-04-152959","volume":"112","author":"M Neyman","year":"2008","unstructured":"Neyman, M., Gewirtz, J. & Poncz, M. Analysis of the spatial and temporal characteristics of platelet-delivered factor VIII-based clots. Blood 112, 1101\u20131108 (2008).","journal-title":"Blood"},{"key":"BFnbt1995_CR32","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1182\/blood.V90.10.3962","volume":"90","author":"HF Lin","year":"1997","unstructured":"Lin, H.F., Maeda, N., Smithies, O., Straight, D.L. & Stafford, D.W. A coagulation factor IX-deficient mouse model for human hemophilia B. Blood 90, 3962\u20133966 (1997).","journal-title":"Blood"},{"key":"BFnbt1995_CR33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood.V91.3.784","volume":"91","author":"SH Kung","year":"1998","unstructured":"Kung, S.H. et al. Human factor IX corrects the bleeding diathesis of mice with hemophilia B. Blood 91, 784\u2013790 (1998).","journal-title":"Blood"},{"key":"BFnbt1995_CR34","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1172\/JCI20106","volume":"113","author":"P Margaritis","year":"2004","unstructured":"Margaritis, P. et al. Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII. J. Clin. Invest. 113, 1025\u20131031 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnbt1995_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/35092573","volume":"413","author":"GR Sambrano","year":"2001","unstructured":"Sambrano, G.R., Weiss, E.J., Zheng, Y.W., Huang, W. & Coughlin, S.R. Role of thrombin signaling in platelets in haemostasis and thrombosis. Nature 413, 74\u201378 (2001).","journal-title":"Nature"},{"key":"BFnbt1995_CR36","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/nm782","volume":"8","author":"S Falati","year":"2002","unstructured":"Falati, S., Gross, P., Merrill-Skoloff, G., Furie, B.C. & Furie, B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat. Med. 8, 1175\u20131181 (2002).","journal-title":"Nat. Med."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nbt.1995.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.1995","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.1995.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:19:30Z","timestamp":1684419570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nbt.1995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,23]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["BFnbt1995"],"URL":"https:\/\/doi.org\/10.1038\/nbt.1995","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13370969.14741069","asserted-by":"object"}]},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,23]]}}}